Diagnoly
PrivateLast Round
Seed
Apr 8, 2025
Total Funding Raised
$7.28M
Company Overview
Diagnoly is a medtech company that provides an AI-powered software platform designed to improve prenatal ultrasound screening.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Computer Vision, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Revenue Share, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diagnoly Comparables
Compare Diagnoly with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioticsAI | 92% | |
| BrightHeart | 92% | |
| Fraiya | 89% | |
Diagnoly Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 8, 2025 | ||||
| Pre Seed | Dec 1, 2021 |
Diagnoly Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Les Business Angels des Grandes Écoles | Pre Seed, Seed |
| Harvard Innovation Labs | Pre Seed |
| Newfund Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2026
Grew 53% QoQ, from 15 to 23 employees.
- Jan 21, 2026
Grew 33% QoQ from 15 to 20 employees.
Diagnoly Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Diagnoly's valuation, stock price, and market status.